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Key questions
What is already known about this subject?
 ► While there have been improvements in the man-
agement of cardiovascular disease, significant 
variation still exists in survival following acute myo-
cardial infarction (AMI) between hospitals within 
England.
 ► Morbidity and mortality outcomes can be supple-
mented by patient-reported outcome measures 
(PROMs), but have not been used widely in routine 
care.
 ► The feasibility of recruiting patients with AMI to 
recall their pre-admission health status has been 
demonstrated, their likelihood of responding to a 
postdischarge mailed PROM questionnaire at 3 
months is unknown.
What does this study add?
 ► PROMs can be successfully collected in patients 3 
months after STEMI with a response rate of 66.3% 
using mailed follow-up.
 ► Most patients regained their prior level of cardi-
ac health as measured by the short form Seattle 
Angina Questionnaire. The physical limitation sub-
scale score was worse than at baseline, whereas 
the quality-of-life subscale was better.
How might it impact on clinical practice?
 ► PROMs offer the opportunity for routinely assess-
ing the impact of treatment from the patient’s 
perspective.
 ► Meaningful comparisons of hospitals based on 
PROMs could be undertaken to supplement clin-
ical measures such as mortality, morbidity and 
complications.
AbstrAct
Introduction Routine measurement of the outcome 
of myocardial infarction is usually limited to immediate 
morbidity and mortality. Our aim was to determine the 
response to patient-reported outcome measures (PROMs) 
3 months later, identify response bias and explore the 
feasibility of comparing outcome with their recalled view 
of their prior health state.
Methods Patients admitted with ST-segment-elevation 
myocardial infarction (STEMI) to five percutaneous 
coronary intervention centres were invited to complete 
a retrospective questionnaire containing the EQ-5D-3L 
and short form Seattle Angina Questionnaire (SAQ-
7). Response rate for a 3-month mailed follow-up 
questionnaire and potential response biases were 
assessed. Patients’ outcomes were compared with 
their baseline using χ2 and paired t-test to assess for 
differences.
Results Of 392 patients contacted, 260 (66.3%) 
responded. Responders were more likely to be older, 
female, more affluent and have a higher EQ-5D at 
baseline. Three months after surgery, patients’ SAQ-7 and 
angina symptom subscale returned to their baseline score. 
The physical limitation subscale score was worse than at 
baseline (79.9 vs 73.2, p=0.002), whereas the quality-
of-life subscale was better (66.6 vs 73.9; p<0.001). The 
EQ-5D-3L index score was similar at 3 months to baseline 
(0.82 vs 0.79). Evidence of bias arising from responders 
being in better general health at baseline needs further 
investigation and, if confirmed, needs to be taken into 
account in interpreting PROMs data.
Conclusion It is feasible to use PROMs routinely to 
assess the impact of emergency admissions of patients 
with STEMI. A larger demonstration project with more sites 
is needed to confirm these findings.
IntRoduCtIon
Despite the number of emergency admissions 
to hospital increasing and concern about 
variations in outcomes between providers,1 2 
no attempt has been made to use patient-re-
ported outcome measures (PROMs) to deter-
mine patients’ perception of their change 
in health status. In England, emergencies 
account for about 40% of all hospital admis-
sions, with the number of admissions having 
increased by 47% over the last 15 years.3 
Two-thirds of hospital beds are occupied by 
emergencies and the cost to the National 
Health Service (NHS) is approximately £12.5 
billion annually.4
Measuring the quality of healthcare is 
paramount for all health systems. PROMs 
is one of the ways to measure effectiveness 
and to determine the benefit of resources 
spent.5 6 PROMs are self-reported question-
naires designed to be completed by patients 
to capture their health at specific points in 
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time to detect a health change over a period. They are 
multidimensional measures which may cover symptoms, 
functional status or health-related quality of life. Health 
status and quality of life are outcomes that are highly rele-
vant and important to patients alongside traditional clin-
ical outcomes and survival.6 7
While there have been improvements in the manage-
ment of cardiovascular disease, significant variation still 
exists in survival following acute myocardial infarction 
(AMI) between hospitals within England.8 However, 
nothing is known about whether PROMs of survivors also 
vary between healthcare providers in England as routine 
assessment is limited to clinical outcomes (mortality and 
morbidity). Although there have been no attempts in 
England to routinely capture patients’ recovery using 
PROMs, they have been used in clinical trials. However, 
the extent to which such outcomes reflect those obtained 
in routine clinical care is unclear. There have been 
attempts to collect longer-term outcomes of patients with 
AMI in the USA, but whether those results are transfer-
able to the English NHS is unclear.9–12
If the aim of healthcare is to restore a patient to his or 
her full potential, we need to be able to compare patients’ 
outcomes with their health status before the sudden and 
unexpected event that leads to the emergency admission. 
To determine the feasibility of employing PROMs in emer-
gency NHS admissions, an exploratory feasibility study 
was conducted in patients admitted with ST-segment-el-
evation myocardial infarction (STEMI).13 Success of 
recruiting patients soon after admission and of obtaining 
their recollected state of health prior to their admission 
to provide a baseline assessment has been reported.13–15
In this paper, we report on the follow-up response rate 
for patients who, following an emergency admission, 
were confirmed to have suffered a STEMI, meeting the 
PPCI assessment checklist for inclusion and who under-
went emergency (primary) percutaneous coronary inter-
vention (PCI). Secondary objectives were to quantify any 
response bias as regards sociodemographic character-
istics, comorbidity and health status and determine its 
potential impact on outcome assessment. Being an initial 
feasibility study, it was not powered sufficiently to make 
meaningful comparisons between participating centres.
MetHods
site and patient recruitment
A multisite study was carried out to ensure there would 
be variation in the administration of patient recruitment 
and data collection. This would provide insights into the 
relative merits of recruiting in different settings and with 
different personnel involved.16 For practical reasons, 
the study was confined to one region of England (North 
Thames). Five primary angioplasty centres were invited 
through the National Institute for Health Research 
(NIHR) Collaborations for Leadership in Applied Health 
Research and Care partnership network, and all agreed 
to participate.
Patients admitted with STEMI to the five centres who 
were alive at discharge were eligible for inclusion unless 
they were not literate in English, judged not to have suffi-
cient cognitive ability or were not residents in the UK.
Patients were invited to participate soon after their 
primary PCI and as close to the discharge date as possible 
to ensure the immediate effects of the intervention were 
minimised. Clinical staff explained the study to patients, 
provided written information and obtained written 
consent. Questionnaires recalling their pre-admission 
baseline health status were completed by patients without 
assistance from staff or family except when they were 
impeded by physical disability or sensory impairment.
Full details of the study methods and feasibility of 
recruitment have been described elsewhere.13
Patients were sent a follow-up questionnaire by mail 
from the London School of Hygiene and Tropical 
Medicine 12 weeks after their admission to hospital. 
Patient vital status was checked against the Personal 
Demographics Service at NHS Digital prior to sending 
a follow-up questionnaire. Non-responders after 2 weeks 
were sent a reminder questionnaire.
Questionnaires
The questionnaires completed during the admission 
included demographic information, self-reported comor-
bidities, a disease-specific PROM and a generic PROM. 
Patients were asked to recall how they were 1 month 
before their admission.
The disease-specific PROM used was the short form 
Seattle Angina Questionnaire (SAQ-7 UK version). This 
is a seven-item health status measure for patients with 
coronary artery disease that has well-established validity, 
reliability, sensitivity to clinical change, and prognostic 
value.17–19 Scores range from 0 to 100, where higher 
scores indicate fewer symptoms and higher health-re-
lated quality of life. SAQ-7 has good domain coverage 
(symptom burden, functional status and quality of life), 
psychometric properties (validity, sensitivity), feasibility 
to implement (questionnaire length, language avail-
ability and cost to implement) and clinical interpret-
ability (knowledge of how to interpret scores in a clinically 
meaningful way).20 It assesses five dimensions: exertional 
capacity, angina stability, angina frequency, treatment 
satisfaction and disease perception. Three subscales can 
be derived: physical limitation; angina symptoms; quality 
of life (SAQ-QoL). The summary scale and the three 
subscales extend from 0 (worst possible health state) to 
100 (best possible health state). The SAQ-7 has been 
previously validated and applied in patients with acute 
coronary syndrome.17 18
The generic PROM used was the EQ-5D-3L which has 
five items: mobility, usual activities, personal care, pain/
discomfort and anxiety/depression. It takes up to 5 min 
to complete.21 For each item, the patient chooses from 
three possible responses indicating the level of their 
function. A multi-attribute utility score where death and 
perfect health are represented by 0 and 1 is calculated.22 
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Scores less than 0 are considered worse than death and 1 
is the maximum score possible. The EQ-5D-3L was used 
rather than the EQ-5D-5L as the former is still the version 
used in the National PROMs Programme in England.
Analysis
Participating patients’ characteristics were summarised 
using means and SDs for continuous variables or percent-
ages for categorical variables. Response rates were calcu-
lated and reported for patients grouped by age, sex, 
living arrangements, socioeconomic status (SES), base-
line SAQ-7 scores and baseline EQ-5D-3L scores. SES was 
measured using the English Index of Multiple Depriva-
tion (IMD) based on patients’ residential postcodes23 
with patients assigned to quintiles of the national ranking 
of IMD scores.
SAQ-7 scores and subscales were calculated according 
to scoring instructions of the questionnaire developers 
whereby partial responses were included where possible. 
Furthermore, individuals with non-responses to two or 
more items in a subscale did not contribute to the calcu-
lation of the component score as per scoring instructions 
provided by the developers of the SAQ-717
The likelihood of responding according to several 
patient characteristics (age, sex, SES, comorbidities, base-
line SAQ-7 and EQ-5D-3L) was calculated. This allowed 
the likely impact of non-response on the observed 
change in SAQ-7 and EQ-5D-3L to be estimated for the 
patient characteristics shown have a statistically signifi-
cant non-response association, based on the assumption 
that non-responders would have reported similar PROM 
changes as responders.
Patients’ outcomes at 3 months were compared with 
their baseline using χ2 and paired t-test to assess evidence 
of change in health status. Change scores, with the 95% 
CIs, were also used to describe reasonable limits on the 
extent of any change in order to assess whether the results 
were consistent with recovery to baseline (no change or 
an improvement in scores).
Results
Response rates
A total of 396 patients were recruited and completed 
questionnaires (Q1) recalling their health state 1 month 
earlier (online supplementary appendix 1). Of these, 
four (1%) died during the follow-up period. Of the 
392 survivors, 260 patients (66.3%) responded to the 
follow-up PROM questionnaire (QF), 216 responded to 
the first request and 44 after one reminder.
The mean time between completing the baseline and 
the follow-up questionnaire was 89 (SD 17) days and 
between admission and follow-up questionnaire, 92 days.
Response bias
Responders and non-responders were similar as regards 
comorbidities, living arrangements and disease-specific 
PROM score (SAQ-7) (table 1). Responders differed 
from non-responders in other ways: they were older 
(mean age 64.3 SD 12; range 35–94 vs 57.1, SD 10; range 
28–79, p<0.0001) (figure 1), more likely to be women, 
more likely to come from more affluent SES and have a 
higher generic PROM score (EQ-5D-3L) at baseline.
Comparing change in PRoM scores
The distribution of the EQ-5D-3L at baseline has a left 
skew, with the majority of patients between 0.8 and 1.0 
and a small minority having scores below 0.5 indicating 
poor health-related QoL. The SAQ-7 score distribution at 
baseline also has a left skew but to a lesser extent than the 
EQ-5D index (figure 2) .
Three months after AMI, patients’ mean SAQ-7 score 
and mean angina symptom subscale was similar to their 
baseline score (table 2). In contrast, the physical limita-
tion subscale was worse than at baseline (79.9 vs 73.2, 
p=0.002) while the SAQ-QoL subscale had improved (66.6 
vs 73.9; p<0.001). The EQ-5D-3L index score was slightly 
lower at 3 months than at baseline (0.82 vs 0.79, p<0.02) 
though its statistical significance, however, appears to be 
due to a change in the shape of the distribution rather 
than a shift in distribution.
Influence of non-response on change in health status
Changes following STEMI and PCI in most PROM scores 
(the SAQ-7, SAQ-7 subscales and EQ-5D-3L) were not 
significantly associated with patient characteristics. The 
one exception was that patients in the poorest health (as 
determined by their baseline EQ-5D-3L score) reported 
significantly larger (p<0.001) improvements in their 
EQ-5D scores at 3 months (table 3).
Assessment of non-response bias
Assessment of potential biases that might have been intro-
duced by some patients not responding was based on the 
assumption that patients with similar baseline EQ-5D 
index scores would have had similar follow-up EQ-5D 
or SAQ scores. To illustrate the impact on non-response 
linked to baseline EQ-5D (mean 0.82 in responders vs 
0.79 in non-responders; table 1), we estimated the mean 
change in SAQ and EQ-5D scores had there been 100% 
follow-up response rate, compared with the observed 
mean changes . The mean change in SAQ-7 would have 
been 1.2 (for all participants including non-responders) 
compared with 0.8 (observed in responders). The 
observed mean change in EQ-5D-3L would have been 
−0.02 compared with the observed mean change of −0.03.
dIsCussIon
Main findings
Three-month follow-up PROMs can be successfully 
collected from two-thirds of patients admitted as emer-
gencies with STEMI for primary PCI through mailed ques-
tionnaires. Although responders and non-responders 
were similar with regards to their living arrangements, 
number of comorbidities and baseline SAQ-7, responders 
were more likely to be older, female, of a higher social 
economic status and be in better general heath according 
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Table 1 Characteristics of responders (n=260) compared with non-responders (n=132)
Patient characteristics
Overall Responders Non-responders
P valueN (%) N (%) N (%)
Sex
  Male 308 (78.6) 196 (75.4) 112 (84.9) 0.031
  Female 84 (21.4) 64 (24.6) 20 (15.2)
SES
  1 (least deprived) 68 (18.4) 48 (19.4) 20 (16.4) 0.013
  2 60 (16.3) 50 (20.2) 10 (8.20)
  3 91 (24.7) 59 (23.9) 32 (26.2)
  4 94 (25.5) 53 (21.4) 41 (33.6)
  5 (most deprived) 56 (15.2) 37 (15.0) 19 (15.6)
  Missing 23 13 10
Comorbidities
  0 57 (14.6) 35 (13.6) 22 (16.8)
  1 111 (28.5) 76 (29.5) 35 (26.7) 0.904
  2 94 (24.2) 64 (24.8) 30 (22.9)
  3 60 (15.4) 39 (15.1) 21 (16.0)
  4 or more 67 (17.2) 44 (17.1) 23 (17.6)
  Missing 3 2 1
Living arrangements
  With family 296 (75.9) 195 (75.2) 101 (77.1)
  Alone 87 (22.3) 60 (23.2) 27 (20.6) 0.755
  Other 7 (1.79) 4 (1.54) 3 (2.29)
  Missing 2 1 1
Mean EQ-5D-3L (SD) 0.79 (0.28) 0.82 (0.25) 0.73 (0.34) 0.002
Mean SAQ-7 (SD) 76.8 (21.1) 77.8 (22.3) 74.9 (20.4) 0.207
SAQ-7, short form Seattle Angina Questionnaire; SES, socioeconomic status.
Figure 1 Age distribution of responders and non-
responders. PROM, patient-reported outcome measure.
to the EQ-5D-3L score. Apart from the latter, none of these 
characteristics was associated with the change in health 
reported at follow-up so have not introduced any possible 
bias to the findings. However, the higher EQ-5D-3L of 
responders at baseline could introduce some bias leading 
to an underestimation of the improvement in the cardiac 
health of patients 3 months after the event: change in 
SAQ-7 would be 1.2 instead of 0.8. Similarly, the observed 
deterioration in generic health (EQ-5D-3L 0.03 lower at 
follow-up) would be less (0.01 lower).
Three months after PCI, patients’ mean SAQ-7 score 
and angina symptom score returned to their baseline 
score, suggesting patients regain their prior level of 
cardiac health. Although patients reported greater phys-
ical limitation than beforehand, they felt their QoL had 
improved. Given that a clinically meaningful difference 
in SAQ scores is estimated to be 5–8 points, these differ-
ences are clinically important.24
Although the EQ-5D-3L index score was lower at 3 
months when compared with baseline (0.82 vs 0.79), the 
clinical significance of this decrement should be further 
explored as although this reached statistical significance, 
the CIs overlap.
What this study adds
This study has demonstrated the feasibility of collecting 
PROMs 3 months after STEMI among patients who, 
during their admission, had supplied retrospective 
accounts of the pre-event health status. It has shown 
that the response is subject to responder bias which, 
if confirmed in a larger study, would need to be taken 
into account when comparing the outcomes of different 
providers to ensure meaningful findings.
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Figure 2 Short form Seattle Angina Questionnaire (SAQ-7) summary and EQ-5D-3L index score distributions.
Table 2 Comparison of baseline and follow-up PROM scores
PROM
Number with 
complete data
Baseline
Mean (SE, 95% CI)
Follow-up
Mean (SE, 95% CI)
Change (95% CI, P 
value)
SAQ-7 summary 259 77.8 (1.27, 75.3 to 80.3) 78.6 (1.22, 76.2 to 81.03) +0.8 (−1.6 to 3.2, 0.56)
SAQ-7 physical limitation 227 79.9 (1.9, 76.2 to 83.7) 73.2 (1.81, 69.6 to 76.8) −6.7 (−10.3 to −3.1, 0.0018)
SAQ-7 angina symptom 258 86.9 (1.2 to 84.6) 88.6 (14.1, 86.5 to 90.7) +1.7 (−13.3 to 16.7, 0.24)
SAQ-QoL 254 66.6 (1.8, 63 to 70.2) 73.9 (1.7, 70.6 to 77.2) +7.3 (3.9 to 10.7, <0.001)
EQ-5D-3L index 256 0.82 (0.02, 0.79 to 0.85) 0.79 (0.02, 0.76 to 0.82) −0.03 (−0.07 to 0.01, 0.02)
PROM, patient-reported outcome measure; QoL, quality of life; SAQ-7, short form Seattle Angina Questionnaire.
The observation that while patients’ physical limitation 
worsens their QoL improves is surprising. There are three 
possible explanations. First, it may be that patients recall 
their prior QoL as worse than it was, although no such 
bias was detected in studies of elective surgery when retro-
spective and contemporary reports were compared.14 15 
Second, it may be that patients’ baseline disease-specific 
QoL was already lowered due to the presence of subacute 
symptoms prior to their AMI, but were not at the clinical 
threshold that warranted medical attention. Grodzinsky 
et al reported similar baseline SAQ-QoL scores (63.8) in 
patients with AMI as that reported in this study.25
Third, it may be that patients exercised caution in their 
physical exertion and hence imposed greater physical 
limitations on their function than necessary. Meanwhile, 
their QoL may improve from the psychological boost of 
having survived their AMI and had the reassurance of 
having had their coronary arteries stented. This may be 
due to a degree of ‘response shift’ occurring following 
patients’ experience of an AMI. Patients may have a 
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Table 3 Exploring extent of differences in PROM scores and health change with responder characteristics
Patient characteristics
Mean SAQ-7 summary score SAQ-7 summary score 
difference in health 
change, (SD)
(n=259) 
 P value 
Baseline (Q1) score, (SD)
(n=390) 
Follow-up (QF) score, (SD)
(n=260) 
Age
  >70 80.3 (20.5) 78.4 (20.2) −1.88 (25.0) 0.33
  50–70 75.5 (21.0) 78.7 (19.0) 1.72 (22.3)
  <50 75.4 (21.8) 78.9 (20.7) 4.65 (25.5)
Sex
  Male 77.3 (20.7) 80.4 (19.1) 1.92 (23.2) 0.2
  Female 75.2 (22.4) 72.5 (20.7) −2.46 (24.4)
SES
  1 (least deprived) 79.6 (20.0) 83.4 (19.0) 5.89 (20.4) 0.23
  2 80.0 (18.4) 79.5 (18.6) −0.96 (23.8)
  3 78.5 (19.0) 77.2 (19.6) −1.73 (23.0)
  4 72.6 (24.3) 80.4 (21.5) 5.10 (24.5)
  5 (most deprived) 75.1 (20.9) 72.6 (18.8) −2.85 (27.9)
EQ-5D baseline categories
  1 (≤0.65) 59.1 (24.4) 64.5 (23.0) 6.3 (33.8) 0.16
  2 (0.66–0.85) 74.7 (19.2) 76.4 (18.9) 2.4 (24.1)
  3 (0.86–1) 85.5 (15.9) 84.1 (16.7) −1.6 (19.6)
Patient characteristics 
EQ-5D 
P value* 
Baseline score
(n=385) 
Follow-up score
(n=258) 
Difference in health 
change
(n=256) 
Age
  >70 0.80 (0.23) 0.78 (0.26) −0.01 (0.24) 0.41
  50–70 0.80 (0.28) 0.80 (0.22) −0.05 (0.23)
  <50 0.76 (0.36) 0.74 (0.33) −0.04 (0.23)
Sex
  Male 0.80 (0.28) 0.81 (0.24) −0.04 (0.23) 0.81
  Female 0.75 (0.30) 0.71 (0.28) −0.03 (0.23)
SES
  1 (least deprived) 0.85 (0.21) 0.81 (0.23) −0.04 (0.17) 0.38
  2 0.83 (0.23) 0.84 (0.19) −0.01 (0.26)
  3 0.79 (0.23) 0.80 (0.24) −0.01 (0.23)
  4 0.73 (0.37) 0.78 (0.25) −0.02 (0.24)
  5 (most deprived) 0.77 (0.34) 0.70 (0.31) −0.10 (0.22)
EQ-5D baseline
  Categories
  1 (≤0.65) 0.27 (0.28) 0.49 (0.38) 0.19 (0.33) <0.001
  2 (0.66–0.85) 0.78 (0.06) 0.79 (0.17) 0.01 (0.17)
  3 (0.86–1) 0.98 (0.04) 0.86 (0.19) −0.12 (0.19)
*From ANOVA.
PROM, patient-reported outcome measure; SES, socioeconomic status.
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different appreciation of their cardiac-related QoL. All 
PROMs, which are subjective reports, can be influenced 
by response shift.26 The literature on clinical recovery 
trajectories after STEMI at 3 months is sparse with no 
studies reporting the SAQ-7. However, it is reported that 
patients continue to recover and improve their SAQ 
scores for up to 12 months.9 25
strengths and limitations
This is the first study of using retrospective PROMs in 
routine clinical practice to collect patients’ baseline 
health status and 3 months after for those admitted with 
STEMI in England. Conducting it in five trusts demon-
strated the feasibility of PROM use in different hospital 
organisational cultures and environments.
One potential limitation is that despite the left skew 
of the EQ-5D data, we opted to use the same statistical 
test (t-test) for comparisons between the 3 months and 
baseline to preserve consistency comparisons with other 
measures. However, as the t-test does not take into account 
the skew and truncation of the EQ-5D data, the p value 
should be interpreted with caution in this instance and 
the CI is the more appropriate method of interpretation 
of any differences.
Implications on further research/policy
This study shows that it is feasible to collect retrospective 
and follow-up PROMs from patients admitted as emer-
gencies with STEMI in NHS hospitals. This approach 
offers an insight into the opportunity for assessing, from 
the patient’s perspective, the impact of treatment for 
the 40% of hospital admissions that are emergencies 
and patients’ subsequent recovery after their emergency 
admission. The generalisability of these findings to other 
causes of emergency admissions needs to be established.
Further research is warranted to explore longer-term 
outcomes and compare these with patient risk profiles 
and clinical characteristics to recovery trajectories.
Routine collection of PROMs in emergency admis-
sions is feasible using the retrospective PROMs collected 
during the index admission and a subsequent contempo-
rary follow-up. Data could be linked to clinical measures 
known to be associated with outcome (such as Kilip classi-
fication, concentration of Tnl, infarct site and left ventric-
ular ejection fraction) and quality dashboards to support 
on-going quality improvement through benchmarking, 
by promoting clinical effectiveness and patient-centred 
care. Larger studies are needed to collect PROMs in 
patients admitted with AMI and other patients with emer-
gency acute coronary syndrome to enable subgroup anal-
ysis of patient and clinical characteristics, to investigate 
further any response bias and to develop risk adjustment 
models to enable comparisons of providers.
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